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Insight into the regulation of the actions of the protein-tyrosine kinases will be greatly facilitated by the full characterization of the family of protein- 
tyrosine phosphatases. A search for novel phosphatases resulted in the isolation of a cDNA, termed HLPR, encoding a member of the family 
of human receptor-like protein-tyrosine phosphatases: its cDNA sequence predicts a protein of 793 amino acids (unglycosylated M, 87500) and 
includes a 121 residue extracellular domain, a single transmembrane segment, and two tandem intracytoplasmic catalytic domains. The HLPR 
gene is located on human chromosome 20, and the protein it encodes likely plays a fundamental role in the physiology of al] cells as its expression 
appears to be ubiquitous. 
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1. INTRODUCTION 
The phosphorylation of specific tyrosine residues 
within proteins catalysed by protein-tyrosine kinases 
(PTK) represents a pivotal component of the control of 
cellular functions such as signal transduction, cell pro- 
liferation, and oncogenesis [11. The regulation of such 
cellular activities is likely determined in part by a 
balance between phosphorylation and dephosphoryla- 
tion, the latter being mediated by protein-t~osine 
phosphatases (PTPase). Hetero8enous PTPase ac- 
tivities have been detected and characterized in both 
soluble and particulate fractions derived from a wide 
array of cell types and tissues [2,3] suggesting the ex- 
istence of a diverse, ubiquitously expressed, PTPase 
gene family. 
The first PTPase whose protein sequence was deter- 
mined was a low molecular weight single catalytic do- 
main species from human placenta, termed PTPase 1B 
[4,5]. This protein was discovered to possess homology 
with the intracellular imperfect tandem repeats of the 
leukocyte ~mmon antigen, (CD45), a receptor-like 
transmembr~e molecule expressed on cells of 
hemopoietic origin [6], In addition to CD45, several 
other receptor-like PTPases have been isolated, in- 
cluding: LAR [7 1, DLAR and DPTP [8], and LRP [9]. 
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In T-lymphocytes, CD45 may catalyse the 
dephosphorylation of tyrosine-505 of Ick, thus leading 
to a stimulation of this PTK [lo-131. Conversely, 
insulin-induced Xenopus Iaevis oocyte maturation is in- 
hibited following the microinjection of PTPase 18 pro- 
tein [14]. 
Thus, the activity of a given PTPase may regulate the 
actions of a PTK in a positive or negative manner. Fur- 
thermore, adding a further layer of regulation, the 
receptor-like PTPases are themselves likely regulated 
via interaction with specific ligands. Herein, we report 
the isolation of a widely expressed member of the fami- 
ly of human receptor-like PTPases which is 
homologous to the murine PTPase LRP [9]. 
2. MATERIALS AND METHODS 
The human hepatoblastoma cell line Hep G2 (American Type 
Tissue Collection-ATCC, Rockville, MD) was used to obtain total 
RNA (151. Poly(A)+ RNA isolated by oligo(dT)-cehulose 
chromatography [16] was used to construct a cDNA library in the 
bacteriophage vector ZAP (Stratagene, La Jolla, CA). Filter lifts of 
recombinant bac~~ophage plaques, grown on Escherichia cofi strain 
XLI-Blue (Stratagene), were screened by standard methods [16]. For 
probes DNA fragments were “P-labeled using a random labehng kit 
(Pharmacia, Uppsala, Sweden). The probe employed in library 
screening consisted of a 1.5 kb BsmI to SphI DNA fragment spanning 
the two PTPase domains of murine CD45 [17]. Filter lifts were wash- 
ed at low stringency in 2 x SSC (0.3 M NaCl, 0.03 M sodium citrate, 
pH 7.0) with 0.1% sodium-dodecylsulfate at 45°C followed by 
autoradiography on XAR-5 film (Kodak, Rochester, NY). 
Hybridizing clones were ‘rescued’ according to the manufacturers 
instructions (Stratagene). Double-stranded DNA sequencing was per- 
formed [18] using the T7, KS, T3, and SK oligonucleotide primers 
(Statagene), as well as synthetic oligonucleotide primers using a 
modified n-DNA polymerase sequencing kit (Pharmacia). Gverlap- 
ping sense and anti-sense strands were sequenced. 
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Total cellular RNA from cell lines and tissues [15] was subjected to 
Northern blotting [16]. cDNA restriction fragments were labeled as 
above for use as probes. Washing and autoradiography were carried 
out as above except that membranes were washed at SO-55°C in 0.2 
x ssc. 
Corp., New Haven, CT) were probed with labeled cDNA fragments 
and processed according to the manufacturer’s instructions. 
3. RESULTS AND DISCUSSION 
For chromosomal assignment, membranes containing transferred 
Hind111 digested DNA from hamster-human hybrid panels (BIOS 
Screening of the Hep G2 cell line library yielded 
several phage clones, which were ‘rescued’ as plasmids. 
GTGGTAAn;G~~AGTTCAAATAACTAAGGACACA~TTC~GAGCAT~TT~CTTTTT~G~GCTAGACTTCTTC 
AGAAGCTTGCCAGTTTTTCACTGATTTCTCTCACTGGC~CTCTTCAGAGTGCTGTTCCTACTCCACCCTCCCCTGGTGAT~ 




T S LSVVAP T F S P N I T LGPTYLTTVNSSS 84 
ACTTCTCTTTCTGTGGCACCATTCAGCCCAAATATAATCTG 
DNGTT R T A S T N S I GITISPNGTWLPDNQF113 
ACAATGGGACCACAAGAACC~TTCTATAGGTT 




K Y K Q A G S H S N S F R L S N...G R T E D G E P Q C V P L 198 
AATACAAGCAAGCTGGGAGCCATTCCAATTCC~TTCTTTCC~TTATCC~CGGCC~ACTGAGGAT~TGAGCCCCAGTGTGTGCACTC 
L A R S P STNRKYPP L P V D K L E E E I N R R M A 226 
TCTGGCCAGATCCCCAAGCACCAACAGGAAATACCCACCCACCCCTGCCCGTGGAC~~TGG~GAGG~TT~CCGGAG~TGGCA 
D 9 N K L FREEFNALP A C P IQATCEAASKE 254 
GACGACAATAAGCTCTTCAGGGAGGAATTCAACGCTCTCCGGAGG 
ENKEKNRYVNILP YDHSRVH L T P V E G V P D 283 
AAAACAAGGAAAAAAA TCGATATGTAkACATCTTGCCTTATGACCACTCTAGAGTCCACCTGACACCGGTTG~GGGGTTCCAGA 
S DY I N AS F I NG Y Q E KNKF I AAQ GP KE E T 311 
TTCTGATTACATCAATGCTTCATTCATCAACGGTTACCAACG 
V N D F W R M I W E Q N T A T IVMVTNLKERKEC 339 
GTGAATGATTTCTGGCGGATGATCTGGGAACAAAACACAGCCACCATCGTCATGGTTACC~CCTG~GGAGAG~GGAGTGCA 
K C A Q YWPDQGCW TYGNIRVS V E D V T V L V D368 
AGTGCGCCCAGTACTGGCCAGACCAAGGCTGCTGGCTGCTGGACCTATGGG~TATTCGGGTGTCTGTAGAGGATGTGACTGTCCTGGTGGA 
YTVR KF C I QQVG D M T NRKP Q R L I T Q F H F 396 
CTACACAGTACGGAAGTTCTGCATCCAGCAGGTGGGCGACTTT 




HTERKVD VYGFVSRI R A Q R C Q M V Q T D M Q 481 
GCATACAGAACGGAAGGTGGACGTGTATGGCTTTTGTGAGCCGGATCCGGGCA~~GCTGCCAGATGGTGC~CCGATATGCAG 
YVFIYQA LLEHYLYGDTELEVTSLETHL 509 
TATGTCTTCATATACCAAGCCCTTCTGGAGCATTATTATCTCTATGGAGATACAG~CT~GTGACCTCTCTAG~CCCACCTGC 
QKIYNKI PGTSNNGLEEEFKKLTS I K I Q N 538 
AGAAAATTTACAACAAAATCCCAGGGACCAGCAACAATGG 




I A S Q G PLLHTIEDFWRMIWEWKSCSIVML623 
TCGCCAGCCAGGGCCCTCTTCTCCACACAATTGAGGACTTGAGGACTTCTGGCG~TGATCTG~AGT~~TCCTGCTCTATCGTGATGCT 




IRQFHFHG WPEVGIP SDGKGMISI I A A V Q 708 
TCCGGCAGTTCCACTTCCATGGCTGGCCTGAAGTGGGCATCGCCGCCGTGCA 
KQQ Q Q S G N HP I T VH C S AGAG RT G T FCAL 736 
GAAGCAGCAGCAGCAGTCAGGGRACACCCCACCGTGCCTTCTGTGCCCTG 
STVLERVKAEGILDVFQTVKS LRLQRPH 764 
AGCACCGTCCTGGAGCGTGTGAAAGCAGAGA~GATTGGCCTGCGGCTACAGAGGCCACACA 




Fig. 1. Nucleic acid sequence and translated amino acid sequence of the HLRP cDNA. Standard one letter code is used. Potential translational 
start codons, correct initiation AUG, and the termination codon, are indicated in bold print. Potential N-glycosylation sites are marked by a bold 
leter ‘N’. 
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Fig. 2. Autoradiogram showing expression of HLRP in RNA of 
various sources. Lanes contain U-25 pg of total cellular RNA. Ar- 
rows indicate the 28 S and 18 S ribosomal bands. Lanes 1-4, murine 
kidney, thymus, spleen, and liver; lanes 5-8, human Hep G2 
(hepatobl~toma), T24 (bladder), AML193 (myeloid), FHs 173We 
(fibroblast); lanes 9-10, murine 3T3-Swiss, Pam 212 (keratinocyte); 
and lane 11, Rat 1. 
One of these, having a 2.9 kb cDNA insert and a restric- 
tion enzyme map distinct from LAR was selected for 
analysis. The nucleotide sequence of this clone, 
designated HLRP, is shown in Fig. 1. Analysis of 36 
human-hamster hybrids revealed HLRP-specific 
restriction fragments only in the DNA from 3 of 4 
hybrids containing human chromosome 20, no discor- 
dancies were observed with all other human 
chromosomes. Interestingly, PTPase IB has been map- 
ped to a region of chromosome 20 containing the STC 
and hck PTKs [19]. 
The 5 ’ -untranslated sequence contains four upstream 
AUG initiation codons each of which is followed at a 
short distance by an in-frame termination codon. 
Upstream AUG codons, thought to regulate transla- 
256 330 
tion, are found in only a limited number of genes [20], 
although those encoding proto-oncogenes tend to be 
over-represented in this group. The fourth, and likely 
translationally efficient [20] AUG in the HLRP se- 
quence is followed by a 2380 bp open reading frame. 
The position of this start codon is identical to that 
observed in the murine homologue LRP 191. 
Northern blot analysis (Fig. 2) reveals HLRP 
transcripts in a variety of human cell lines. Transcripts 
were also detected in RNA from murine tissues and cell 
lines (Fig. 2). Although not shown, transcripts were 
detected in murine testes, brain, heart, and in primary 
smooth muscle and mast cells. Thus, transcripts 
hybridizing to HLRP probes appear to be ubiquitously 
expressed and in the rodent RNA likely result from 
LRP gene expression. 
The human cell line RNA contains two classes of 
transcripts in the 3-3.5 kb range (Fig. 2). These are 
detected equally well by HLRP cDNA probes made 
from either the extracellular, or the catalytic domains. 
These transcripts may represent ranscription from two 
different promoters, use of different polyadenylation 
signals, or alternate splicing of exons as has been 
observed in the first catalytic domain of the murine 
PTPase LRP [9]. 
The sequence of HLPR (Fig. 1) is predicted to encode 
a protein of 793 amino acids which on leader peptide 
removal [21] yields a predicted A& 87 300 (unglycosy- 
lated). Four domains follow: an extracellular domain, a 
26 residue transmembrane segment, and two tandem in- 
FhPTP lJ1 NKERNRY~ILFYDHSRVHLTF~GV ................. ..FDSOYINAS~INGYQEKNKFIAAQGFKEETVNDFWRWIWE~NTATI~ V 
LAR Dl --F----a-vIa------I--s1D-- ................... -~~~_~__~~_~__~~Q-~~-_T--_LP--HG--___V_-~~~~-”--~ 
DPTP 01 -AC----FD-RR--Of--K-WIN-L ................. ..QTT-----N-VI--K-RK---C----M-S-ID---------HLSI--I L 
CD4S Dl -ON-----D-----IN--Fi-SElN-D ......... ..~~~.~~~~AG~~~~~~~Y~O~FK~FR_Y______~___D__~~-----RA?V-_--- - 
549 623 
RaF* 02 NMKKNRVLQIIFYEFNRVI:PVKRGE .................. .ENTDYVNASFIDGYRQKDSYIASQGPLLHTIEDFWRMIWEWKSCSIVML 
LIU D2 -KF---LVN-M---LT--CLQFI--V .................. ~-~~~~~~~~~~~____Q~~___~____~~~~__~~~~~-~”~~~~---- 
DPTP D2 -NU---SQE----OR----LTFLFM .................. .--sT-I-----E--DNsETF-]A-D-FKN--G------S-~SVTTL--I 
CD45 D2 -KS---NSNV---DY---PL~EL~SKESEHDSDESSDDDSDSK-PSK-I-----MS-WKFEVH--A----KE--G---Q--~QR-VKV---- 
331 421 
SePTP Dl TNLKERKECKCAOIWP..OOGC~YGNIRVSVEDVTVLMYTVRKFCIP()V~DN.TNRKPQRLITQFllFTSWPDFGVFFTFXGHLKfLKKV~AC 
LAR Dl -R-C-KSRV--~---..~-TE-C-L-Q-TLL-TVK-AT----T-ALHKS-ss . . . ..EK-ELR--Q-Hh---H---EY-TPI-A--RR---- 
DPT? Dl ---t-YNM---K---EKVTDTKOF-D-L-KFAQE~TG--IE-TLNVSKNKANVGESSDR-Q---Y-YLT-K--UA-E~-H-II--IRQYNSV 
Q)IS Dl -RCE-GNRN---E---SMEE-T~F-DW-K~NQHKRCF-YIIQKLN-VNKKEK . . ..ATG-EVTHIQ------H---ED-HLL--LRRR-N-F 
621 70R 
RCPTP 02 TELEERMKKCAQ~P..SDGLVSYGOITVFLKKEEECESYZVRDLLV~NTREN 
LAR D2 
. . . ..KSRQIRQFHFHG~..~VGIFSOGKGMISIIAAVQ 
-K-R-"-R-_-R____ ..ICERS~-QYFV-DFHlr-YNNPP_IL-EFK--DA-DG.....Q--T----Q-TD--..-Q-V-KT-E-C-OF-GQ-H 
DPTP 02 S-IGD -FR--PR--A... -DE-Q-DH-I-KYVHS-S-FY--R-EFY---CKXD 
d)rlS D2 
. . . ..DTLKVT--QYN---TMGEV-EvCR-I-ELWQAY 
---KHGDQEI-----G . ..E-KQT----E-D--DTDKSST--L-VFELRHSRRK.... .D--TVY-YQYTN-S..VEQL-AEF-EL--?¶-.Q-v 
422 501 
ItaPT Dl NFQ.......... . ..YAGAIvVHCsAGvGRTGTFWID~LD)3MTERKVDVYGFVSRIRAQR~HVQTDHQYVFIYQALLEHYLYGDTELE 
LAR VI --L............ .O--FH------------C-I_------ER_K"_KT__ I__~_TC~_S_-NY____SD_----~E-__--~AA*C-~--VF 
DPTP Dl YSL . . . . . . . . . . . ..QR-PIL----------- 
CD45 
TL-AL-SLIQPLEE-DS-SI-NT-CDL-H--NFL--SLK--I-l~-R---DTGTF-N-DIC 
Dl SNF............ .Fs-F--------------YIG---EGLEA-N-__ ~~~Y_v~L_a---L___vsaI--IL-~---v~Y~Q~-S--~ 
709 791 
.-- ReP?P 02 KQQQQ 
LAR D2 








Fig. 3. Alignment sequences (one letter code) of HLRP. CD45, LAR, and DPTP. Dl and D2 indicate the first and second catalytic domains of 
each molecule. Residues identical to those of HLRP are represented by dashed lines. Gaps with dotted lines are for alignment optimi~tion. 
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tracellular PTPase catalytic domains; an organization 
typical of receptor-like PTPases. Alignment of the in- 
tracellular sequences of HLRP, LAR, DPTP and CD45 
reveales considerable amino acid sequence identity 
within the catalytic domains of all four molecules (Fig. 
3). In domain one, for example, from residues 256-330, 
331-421, and 422-501, HLRP shares 40%, 13%, and 
34% identical residues, respectively, with the three 
other PTPases. The higher degree of conservation at 
either end of this catalytic domain suggests that the 
more degenerate central region subserves a structural 
function or determines ubstrate specificity. In domains 
one and two, HLRP and LAR share 56% and 52% 
identical amino acids, respectively. In the transmem- 
brane and intracellular domains HLRP shares 99% 
identical residues with the murine LRP. 
The 121 residue extracellular region of HLRP (and 
murine LRP), bears eight potential N-linked and multi- 
ple potential O-linked glycosylation sites, and is of 
modest size compared to the extracellular regions of 
T2OO/CD45 (541 residues), LAR and DLAR (1234 and 
1345 residues), and DPTP (782 residues). This region of 
HLRP, while showing no similarity to these larger 
PTPases, demonstrates 76% identity with the cor- 
responding region of the murine LRP. The modestly 
sized extracellular domain of HLRP likely does not 
serve as a receptor for a soluble ligand, it may instead 
interact with an another membrane bound protein to 
form a complex. 
HLRP represents a new member of the family of 
human receptor-like PTPases that, similar to the recep- 
tor PTKs, demonstrate conservation of their in- 
tracellular catalytic domains yet show considerable 
heterogeneity in their extracellular domains. Its 
widespread distribution suggests that HLRP is fun- 
damental to the physiology of all cells. Furthermore, its 
expression may be coordinated with that of a ubi- 
quitous PTK, such as the insulin receptor. The further 
study of these phosphatases, and particularly the 
characterization of the extracellular and intracellular 
molecules they interact with, may lead to the identifica- 
tion of novel regulatory mechanisms involving interac- 
tions between the PTKs and the PTPases. 
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